icon-folder.gif   Conference Reports for NATAP  
 
  EASL 48th Annual Meeting
April 24th - 28th 2013
The Netherlands, Amsterdam
Back grey_arrow_rt.gif
 
 
 
Healthy Volunteer First-in-Human Evaluation of GS-5816, a Novel Second Generation Broad-Genotypic NS5A Inhibitor With Potential for Once-Daily Dosing
 
 
  Reported by Jules Levin
EASL 2013 April 28 Amsterdam
 
Polina German, Anita A. Mathias, Philip S. Pang, Chris Yang, Lingling Han, John O. Link, John McNally, Brian P. Kearney Gilead Sciences, Inc., Foster City, CA, USA

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif